CA Stock MarketDetailed Quotes

PREV PreveCeutical Medical Inc

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayMarket Closed Jan 17 10:07 ET
13.54MMarket Cap-12.50P/E (TTM)

PreveCeutical Medical Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-130.62%-111.77K
-64.49%-190.6K
38.80%-58.42K
-33.39%-296.97K
-116.29%-37.18K
-3.99%-48.47K
28.14%-115.87K
60.72%-95.46K
47.78%-222.64K
172,987.12%228.21K
Net income from continuing operations
-40.11%-335.75K
-56.98%-361.96K
38.25%-235.4K
13.97%-1.27M
-226.71%-423.07K
69.95%-239.64K
44.65%-230.58K
36.58%-381.19K
14.20%-1.48M
171.16%333.89K
Operating gains losses
----
----
----
----
----
----
----
----
96.09%-789
--0
Depreciation and amortization
4.27%2.54K
1.65%2.52K
0.40%2.5K
-0.35%9.86K
-62.73%2.45K
124.31%2.44K
124.52%2.48K
121.05%2.49K
94.28%9.89K
836.47%6.57K
Asset impairment expenditure
----
----
----
--0
----
----
----
----
--38.82K
----
Remuneration paid in stock
--0
--0
--0
-60.66%131.45K
727.21%42.3K
-99.08%2.83K
-55.20%8.96K
512.97%77.36K
270.96%334.11K
-124.11%-6.74K
Other non cashItems
9.63%86.97K
3.50%79.22K
7.16%79.06K
-19.07%308.99K
127.95%79.34K
-73.35%79.34K
-9.34%76.54K
-73.98%73.78K
-41.52%381.81K
-269.20%-283.9K
Change In working capital
26.17%134.47K
235.27%89.62K
-27.76%95.42K
6.53%527.21K
87.57%261.81K
-25.96%106.57K
-82.16%26.73K
114.70%132.09K
-16.52%494.89K
-52.04%139.58K
-Change in receivables
-1,024.38%-10.81K
-1,868.55%-9.39K
-101.69%-232
657.16%13.11K
-172.30%-2.3K
337.12%1.17K
109.21%531
1,788.02%13.71K
-106.59%-2.35K
34.68%3.18K
-Change in prepaid assets
28.28%-16.53K
147.28%17.07K
-178.26%-6.37K
31.48%-18.47K
249.47%32.55K
-65.78%-23.05K
-337.98%-36.11K
226.02%8.14K
-370.15%-26.96K
-425.86%-21.77K
-Change in payables and accrued expense
25.96%161.8K
31.51%81.94K
-7.47%102.02K
1.60%532.57K
46.39%231.56K
-18.87%128.45K
-55.63%62.31K
63.93%110.25K
-4.19%524.2K
-43.91%158.17K
Cash from discontinued investing activities
Operating cash flow
-130.62%-111.77K
-64.49%-190.6K
38.80%-58.42K
-33.39%-296.97K
-116.29%-37.18K
-3.99%-48.47K
28.14%-115.87K
60.72%-95.46K
47.78%-222.64K
174,306.87%228.21K
Investing cash flow
Cash flow from continuing investing activities
-128
-105.18%-170
76.26%-779
0
0
0
3.28K
-486.12%-3.28K
101.61%850
0
Net PPE purchase and sale
---128
---170
---779
--0
--0
--0
--0
--0
-66.00%850
--0
Net intangibles purchas and sale
----
----
--0
----
----
----
----
---3.28K
----
----
Cash from discontinued investing activities
Investing cash flow
---128
-105.18%-170
76.26%-779
--0
--0
--0
--3.28K
-486.12%-3.28K
101.61%850
--0
Financing cash flow
Cash flow from continuing financing activities
130.07%111.78K
75.74%189.79K
-39.47%60.44K
38.69%293.62K
-61.28%37.2K
15.43%48.59K
55,854.40%107.99K
36.08%99.85K
54.82%211.72K
3,101.87%96.06K
Net issuance payments of debt
114.46%21.78K
-22.23%83.99K
-39.47%60.44K
34.56%293.62K
146.13%236.42K
-457.88%-150.64K
155.60%107.99K
164.10%99.85K
59.57%218.21K
3,101.87%96.06K
Net common stock issuance
--0
----
----
----
----
--0
----
----
----
----
Net other financing activities
----
----
----
----
----
----
----
----
---6.49K
--0
Cash from discontinued financing activities
Financing cash flow
130.07%111.78K
75.74%189.79K
-39.47%60.44K
38.69%293.62K
-61.28%37.2K
15.43%48.59K
55,854.40%107.99K
36.08%99.85K
54.82%211.72K
3,101.87%96.06K
Net cash flow
Beginning cash position
-90.68%234
-53.76%2.81K
-74.54%1.43K
-64.99%5.62K
-31.11%1.68K
-4.81%2.51K
83.49%6.08K
-64.99%5.62K
-89.73%16.06K
-98.27%2.44K
Current changes in cash
-197.52%-118
78.73%-978
12.27%1.24K
66.76%-3.35K
-99.99%18
102.68%121
97.15%-4.6K
100.66%1.11K
97.06%-10.08K
791.19%324.27K
Effect of exchange rate changes
112.64%120
-255.39%-1.6K
120.67%135
-131.96%-842
99.92%-269
-121.98%-949
-99.36%1.03K
-100.42%-653
-100.18%-363
-312.20%-321.09K
End cash Position
-85.98%236
-90.68%234
-53.76%2.81K
-74.54%1.43K
-74.54%1.43K
-31.11%1.68K
-4.81%2.51K
83.49%6.08K
-64.99%5.62K
-64.99%5.62K
Free cash from
-130.88%-111.9K
-69.44%-190.77K
40.05%-59.2K
-33.39%-296.97K
-116.29%-37.18K
-3.99%-48.47K
30.18%-112.59K
59.37%-98.74K
53.77%-222.64K
535.40%228.21K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -130.62%-111.77K-64.49%-190.6K38.80%-58.42K-33.39%-296.97K-116.29%-37.18K-3.99%-48.47K28.14%-115.87K60.72%-95.46K47.78%-222.64K172,987.12%228.21K
Net income from continuing operations -40.11%-335.75K-56.98%-361.96K38.25%-235.4K13.97%-1.27M-226.71%-423.07K69.95%-239.64K44.65%-230.58K36.58%-381.19K14.20%-1.48M171.16%333.89K
Operating gains losses --------------------------------96.09%-789--0
Depreciation and amortization 4.27%2.54K1.65%2.52K0.40%2.5K-0.35%9.86K-62.73%2.45K124.31%2.44K124.52%2.48K121.05%2.49K94.28%9.89K836.47%6.57K
Asset impairment expenditure --------------0------------------38.82K----
Remuneration paid in stock --0--0--0-60.66%131.45K727.21%42.3K-99.08%2.83K-55.20%8.96K512.97%77.36K270.96%334.11K-124.11%-6.74K
Other non cashItems 9.63%86.97K3.50%79.22K7.16%79.06K-19.07%308.99K127.95%79.34K-73.35%79.34K-9.34%76.54K-73.98%73.78K-41.52%381.81K-269.20%-283.9K
Change In working capital 26.17%134.47K235.27%89.62K-27.76%95.42K6.53%527.21K87.57%261.81K-25.96%106.57K-82.16%26.73K114.70%132.09K-16.52%494.89K-52.04%139.58K
-Change in receivables -1,024.38%-10.81K-1,868.55%-9.39K-101.69%-232657.16%13.11K-172.30%-2.3K337.12%1.17K109.21%5311,788.02%13.71K-106.59%-2.35K34.68%3.18K
-Change in prepaid assets 28.28%-16.53K147.28%17.07K-178.26%-6.37K31.48%-18.47K249.47%32.55K-65.78%-23.05K-337.98%-36.11K226.02%8.14K-370.15%-26.96K-425.86%-21.77K
-Change in payables and accrued expense 25.96%161.8K31.51%81.94K-7.47%102.02K1.60%532.57K46.39%231.56K-18.87%128.45K-55.63%62.31K63.93%110.25K-4.19%524.2K-43.91%158.17K
Cash from discontinued investing activities
Operating cash flow -130.62%-111.77K-64.49%-190.6K38.80%-58.42K-33.39%-296.97K-116.29%-37.18K-3.99%-48.47K28.14%-115.87K60.72%-95.46K47.78%-222.64K174,306.87%228.21K
Investing cash flow
Cash flow from continuing investing activities -128-105.18%-17076.26%-7790003.28K-486.12%-3.28K101.61%8500
Net PPE purchase and sale ---128---170---779--0--0--0--0--0-66.00%850--0
Net intangibles purchas and sale ----------0-------------------3.28K--------
Cash from discontinued investing activities
Investing cash flow ---128-105.18%-17076.26%-779--0--0--0--3.28K-486.12%-3.28K101.61%850--0
Financing cash flow
Cash flow from continuing financing activities 130.07%111.78K75.74%189.79K-39.47%60.44K38.69%293.62K-61.28%37.2K15.43%48.59K55,854.40%107.99K36.08%99.85K54.82%211.72K3,101.87%96.06K
Net issuance payments of debt 114.46%21.78K-22.23%83.99K-39.47%60.44K34.56%293.62K146.13%236.42K-457.88%-150.64K155.60%107.99K164.10%99.85K59.57%218.21K3,101.87%96.06K
Net common stock issuance --0------------------0----------------
Net other financing activities -----------------------------------6.49K--0
Cash from discontinued financing activities
Financing cash flow 130.07%111.78K75.74%189.79K-39.47%60.44K38.69%293.62K-61.28%37.2K15.43%48.59K55,854.40%107.99K36.08%99.85K54.82%211.72K3,101.87%96.06K
Net cash flow
Beginning cash position -90.68%234-53.76%2.81K-74.54%1.43K-64.99%5.62K-31.11%1.68K-4.81%2.51K83.49%6.08K-64.99%5.62K-89.73%16.06K-98.27%2.44K
Current changes in cash -197.52%-11878.73%-97812.27%1.24K66.76%-3.35K-99.99%18102.68%12197.15%-4.6K100.66%1.11K97.06%-10.08K791.19%324.27K
Effect of exchange rate changes 112.64%120-255.39%-1.6K120.67%135-131.96%-84299.92%-269-121.98%-949-99.36%1.03K-100.42%-653-100.18%-363-312.20%-321.09K
End cash Position -85.98%236-90.68%234-53.76%2.81K-74.54%1.43K-74.54%1.43K-31.11%1.68K-4.81%2.51K83.49%6.08K-64.99%5.62K-64.99%5.62K
Free cash from -130.88%-111.9K-69.44%-190.77K40.05%-59.2K-33.39%-296.97K-116.29%-37.18K-3.99%-48.47K30.18%-112.59K59.37%-98.74K53.77%-222.64K535.40%228.21K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.